Ipamorelin 5mg is a selective growth hormone secretagogue supplied for preclinical research investigating GH regulation and somatotrope physiology in carefully controlled systems and experiments. This formulation supports controlled laboratory studies of GHS-R6 peptide receptor agonism and GH secretion mechanisms in isolated pituitary and in-vitro systems.

Chemical Compound Information:

• Chemical Name: Ipamorelin (alanyl-glutamyl-leucyl-lysyl-prolyl-leucinamide)
• Molecular Formula: C₃₈H₆₉N₁₁O₁₀
• Molecular Weight: ~711.96 Da
• Compound Class: Synthetic pentapeptide; GHS-R6 selective agonist

Description:
Ipamorelin is a selective growth hormone secretagogue peptide with high specificity for GHS-R6. The 5mg formulation enables systematic investigation of GH secretion dynamics and somatotrope responsiveness in preclinical cell culture and tissue preparation models.

Research Applications:

• Investigation of ipamorelin binding kinetics and GHS-R6 receptor selectivity profiles
• Study of GH secretion profiles in cultured pituitary somatotrope cell populations
• Evaluation of secretagogue effects on GHRH and somatostatin physiological interactions
• Assessment of GH pulsatility pattern changes following peptide exposure and treatment
• Examination of pentapeptide stability and receptor engagement duration in laboratory conditions

Storage and Handling:

• Store powder at -20°C in sealed, desiccated containers
• Prepare solutions in sterile PBS or distilled water for experiments
• Maintain working solutions at 2-8°C; use within 48 hours
• Minimize freeze-thaw cycles; utilize single-use aliquots when possible

Product Specifications:

• Purity: >98% by HPLC
• Form: Lyophilized powder
• Quantity: 5mg per vial
• Appearance: White fine powder

FOR RESEARCH USE ONLY. Not intended for human consumption or clinical use. All products are sold strictly for laboratory, educational, and scientific research purposes.